NCT02955030View on ClinicalTrials.gov

Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

September 30, 2017

Conditions
Influenza
Interventions
BIOLOGICAL

NSV0001

sublingual

BIOLOGICAL

"Influenza HA vaccine Biken HA"

subcutaneous

BIOLOGICAL

Placebo

sublingual

Trial Locations (1)

532-0003

OPHAC Hospital, Osaka

Sponsors
All Listed Sponsors
lead

Nitto Denko Corporation

INDUSTRY